OMERS ADMINISTRATION Corp bought a new position in Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 7,300 shares of the company's stock, valued at approximately $231,000. OMERS ADMINISTRATION Corp owned approximately 0.13% of Nutex Health as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in NUTX. Drive Wealth Management LLC bought a new stake in Nutex Health in the fourth quarter worth approximately $1,122,000. Baader Bank Aktiengesellschaft bought a new stake in Nutex Health in the fourth quarter worth approximately $206,000. Legato Capital Management LLC grew its position in Nutex Health by 26.8% in the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock worth $1,004,000 after acquiring an additional 6,697 shares in the last quarter. Truist Financial Corp grew its position in Nutex Health by 22.2% in the fourth quarter. Truist Financial Corp now owns 35,570 shares of the company's stock worth $1,127,000 after acquiring an additional 6,454 shares in the last quarter. Finally, Essex Investment Management Co. LLC grew its position in Nutex Health by 45.4% in the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock worth $3,353,000 after acquiring an additional 33,024 shares in the last quarter. 5.32% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research firms have commented on NUTX. Benchmark boosted their target price on shares of Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 15th. Wall Street Zen downgraded shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday. Finally, Maxim Group upped their price objective on shares of Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a report on Tuesday, May 20th.
Read Our Latest Analysis on NUTX
Insider Activity at Nutex Health
In related news, CFO Jon Christian Bates bought 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the purchase, the chief financial officer now directly owns 4,888 shares in the company, valued at $399,887.28. This trade represents a 25.72% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 38.52% of the company's stock.
Nutex Health Stock Performance
Shares of NASDAQ NUTX traded down $1.91 during trading hours on Monday, hitting $159.95. 66,446 shares of the stock were exchanged, compared to its average volume of 68,643. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The company's 50 day moving average is $115.72 and its 200 day moving average is $67.62. The firm has a market capitalization of $890.28 million, a P/E ratio of -17.04 and a beta of -0.10. Nutex Health Inc. has a one year low of $4.16 and a one year high of $184.28.
Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $2.71. The business had revenue of $211.79 million during the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.
Nutex Health Company Profile
(
Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
See Also

Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.